Oncology reports

Keyphrases

Publications

volume 52, number 4, 2024

Zheng-Ming Zhu, Zheng-Rong Li, Yan Huang, Hai-Hong Yu, Xiao-Shan Huang, Yu-Feng Yan, Jiang-Hua Shao, He-Ping Chen
[Corrigendum] DJ‑1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway. Oncology reports 52 (4) (2024)
Charles Adolfu Shirima, Coralia Bleotu, Demetrios A Spandidos, Adel K El-Naggar, Gratiela Gradisteanu Pircalabioru, Ioannis Michalopoulos
Epithelial‑derived head and neck squamous tumourigenesis (Review). Oncology reports 52 (4) (2024)
Chong Zhang, Shuang-Shuang Zhou, Xiang-Rong Li, Bao-Ming Wang, Neng-Ming Lin, Lin-Yi Feng, Da-Yong Zhang, Li-Huang Zhang, Un-Bo Wang, Jian-Ping Pan
[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo . Oncology reports 52 (4) (2024)
Yuya Sugimoto, Koichi Okamoto, Hiroto Saito, Takahisa Yamaguchi, Jun Kinoshita, Keishi Nakamura, Takahisa Takino, Yoshio Endo, Itasu Ninomiya, Tetsuo Ohta, Noriyuki Inaki
Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts. Oncology reports 52 (4) (2024)
Gang Xu, Lei Meng, Dawei Yuan, Kang Li, Yong Zhang, Chengxue Dang, Kun Zhu
[Retracted] MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer. Oncology reports 52 (4) (2024)
Liang Xu, Xi-Jie Chen, Qian Yan, Xin-Tao Lei, Hai-Ling Liu, Jing-Ping Xu, Wei-Te Shang, Jing-Lin Huang, Zhi-Ting Chen, Xiao-Li Tan, Han-Jie Lin, Xin-Hui Fu, Li-Sheng Zheng, Ping Lan, Yan Huang
Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer. Oncology reports 52 (4) (2024)
Wei Wei, Xiaoliang Zhao, Jianquan Zhu, Lianmin Zhang, Yulong Chen, Bin Zhang, Yue Li, Meng Wang, Zhenfa Zhang, Changli Wang
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling. Oncology reports 52 (4) (2024)
Liang Xu, Xi-Jie Chen, Qian Yan, Xin-Tao Lei, Hai-Ling Liu, Jing-Ping Xu, Wei-Te Shang, Jing-Lin Huang, Zhi-Ting Chen, Xiao-Li Tan, Han-Jie Lin, Xin-Hui Fu, Li-Sheng Zheng, Ping Lan, Yan Huang
Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer. Oncology reports 52 (4) (2024)
Xiaoguang Wang, Zhengwei Song, Biwen Hu, Zhenwei Chen, Fei Chen, Chenxi Cao
[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1. Oncology reports 52 (4) (2024)
Suyeon Park, Shihyun Kim, Moon-Young Kim, Sang Shin Lee, Jongho Choi
Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner. Oncology reports 52 (4) (2024)
Hongxia Cui, Jiaxin Yuan, Xiaohui Du, Ming Wang, Liling Yue, Jicheng Liu
[Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt‑NF‑κB signaling. Oncology reports 52 (4) (2024)
Nilgun Tuncel Cini, Manuela Pennisi, Sidika Genc, Demetrios A Spandidos, Luca Falzone, Panayiotis D Mitsias, Aristides Tsatsakis, Ali Taghizadehghalehjoughi
Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review). Oncology reports 52 (4) (2024)
Jin Wang, Haihua Huang, Xiaomiao Zhang, Haitao Ma
[Retracted] LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑ HSPA9 . Oncology reports 52 (4) (2024)
Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian, Milla Koistinaho, Anu Muona, Amina Zoubeidi
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology reports 52 (4) (2024)
Min Zhou, Lin Wei, Renfu Lu
Emerging role of sirtuins in non‑small cell lung cancer (Review). Oncology reports 52 (4) (2024)
Chong Zhang, Shuang-Shuang Zhou, Xiang-Rong Li, Bao-Ming Wang, Neng-Ming Lin, Lin-Yi Feng, Da-Yong Zhang, Li-Huang Zhang, Un-Bo Wang, Jian-Ping Pan
[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo . Oncology reports 52 (4) (2024)
Gang Xu, Lei Meng, Dawei Yuan, Kang Li, Yong Zhang, Chengxue Dang, Kun Zhu
[Retracted] MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer. Oncology reports 52 (4) (2024)
Shuhao Huang, Zihao Qin, Feiyang Wang, Yiping Kang, Biqiong Ren
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review). Oncology reports 52 (4) (2024)
Liang Xu, Xi-Jie Chen, Qian Yan, Xin-Tao Lei, Hai-Ling Liu, Jing-Ping Xu, Wei-Te Shang, Jing-Lin Huang, Zhi-Ting Chen, Xiao-Li Tan, Han-Jie Lin, Xin-Hui Fu, Li-Sheng Zheng, Ping Lan, Yan Huang
Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer. Oncology reports 52 (4) (2024)
Hongxia Cui, Jiaxin Yuan, Xiaohui Du, Ming Wang, Liling Yue, Jicheng Liu
[Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt‑NF‑κB signaling. Oncology reports 52 (4) (2024)
Shuhao Huang, Zihao Qin, Feiyang Wang, Yiping Kang, Biqiong Ren
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review). Oncology reports 52 (4) (2024)
Min Zhou, Lin Wei, Renfu Lu
Emerging role of sirtuins in non‑small cell lung cancer (Review). Oncology reports 52 (4) (2024)
Tong Wang, Xu Ye, Hao Jiang, Yu Gao
Histone deacetylase inhibitor and PD‑1 blockade synergistically inhibit B‑cell lymphoma progression in mice model by promoting T‑cell infiltration and apoptosis. Oncology reports 52 (4) (2024)
Suyeon Park, Shihyun Kim, Moon-Young Kim, Sang Shin Lee, Jongho Choi
Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner. Oncology reports 52 (4) (2024)
Nilgun Tuncel Cini, Manuela Pennisi, Sidika Genc, Demetrios A Spandidos, Luca Falzone, Panayiotis D Mitsias, Aristides Tsatsakis, Ali Taghizadehghalehjoughi
Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review). Oncology reports 52 (4) (2024)
Zhao Zhao, Yi-Sheng Sun, Wei Chen, Long-Xian Lv, Yong-Quan Li
[Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway. Oncology reports 52 (4) (2024)
Shuhao Huang, Zihao Qin, Feiyang Wang, Yiping Kang, Biqiong Ren
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review). Oncology reports 52 (4) (2024)
Yuya Sugimoto, Koichi Okamoto, Hiroto Saito, Takahisa Yamaguchi, Jun Kinoshita, Keishi Nakamura, Takahisa Takino, Yoshio Endo, Itasu Ninomiya, Tetsuo Ohta, Noriyuki Inaki
Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts. Oncology reports 52 (4) (2024)
Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian, Milla Koistinaho, Anu Muona, Amina Zoubeidi
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology reports 52 (4) (2024)
Yuya Sugimoto, Koichi Okamoto, Hiroto Saito, Takahisa Yamaguchi, Jun Kinoshita, Keishi Nakamura, Takahisa Takino, Yoshio Endo, Itasu Ninomiya, Tetsuo Ohta, Noriyuki Inaki
Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts. Oncology reports 52 (4) (2024)
Zheng-Ming Zhu, Zheng-Rong Li, Yan Huang, Hai-Hong Yu, Xiao-Shan Huang, Yu-Feng Yan, Jiang-Hua Shao, He-Ping Chen
[Corrigendum] DJ‑1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway. Oncology reports 52 (4) (2024)
Nilgun Tuncel Cini, Manuela Pennisi, Sidika Genc, Demetrios A Spandidos, Luca Falzone, Panayiotis D Mitsias, Aristides Tsatsakis, Ali Taghizadehghalehjoughi
Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review). Oncology reports 52 (4) (2024)
Batkhishig Munkhjargal, Kazuya Kondo, Shiho Soejima, Bilguun Tegshee, Michiko Yamashita, Naoya Kawakita, Hiroaki Toba, Hiromitsu Takizawa
DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma. Oncology reports 52 (4) (2024)
Liang Xu, Xi-Jie Chen, Qian Yan, Xin-Tao Lei, Hai-Ling Liu, Jing-Ping Xu, Wei-Te Shang, Jing-Lin Huang, Zhi-Ting Chen, Xiao-Li Tan, Han-Jie Lin, Xin-Hui Fu, Li-Sheng Zheng, Ping Lan, Yan Huang
Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer. Oncology reports 52 (4) (2024)
Xiaoguang Wang, Zhengwei Song, Biwen Hu, Zhenwei Chen, Fei Chen, Chenxi Cao
[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1. Oncology reports 52 (4) (2024)
Zhao Zhao, Yi-Sheng Sun, Wei Chen, Long-Xian Lv, Yong-Quan Li
[Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway. Oncology reports 52 (4) (2024)
Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian, Milla Koistinaho, Anu Muona, Amina Zoubeidi
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308. Oncology reports 52 (4) (2024)
Jin Wang, Haihua Huang, Xiaomiao Zhang, Haitao Ma
[Retracted] LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑ HSPA9 . Oncology reports 52 (4) (2024)
Min Zhou, Lin Wei, Renfu Lu
Emerging role of sirtuins in non‑small cell lung cancer (Review). Oncology reports 52 (4) (2024)

volume 52, number 5, 2024

Shan Xu, Ning Zhao, Lian Hui, Min Song, Zi-Wei Miao, Xue-Jun Jiang
[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3. Oncology reports 52 (5) (2024)
Huan Gui, Yujie Nie, Haohua Yuan, Qianyu Jing, Linzhao Li, Lan Zhu, Shuanghui Chen, Mengjiao Wang, Quan Wan, Hang Lv, Yingjie Nie, Xiangyan Zhang
The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence. Oncology reports 52 (5) (2024)
Liucui Chen, Piaorong Zeng, Huifang Tang, Gang Chen, Juan Xie, Xiaoyan Yang, Xiaoyong Lei
Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (Review). Oncology reports 52 (5) (2024)
Qi Zhong, Duo Li, Xiao-Ping Yang
Progress in antitumor mechanisms and applications of phenformin (Review). Oncology reports 52 (5) (2024)
Wanli Liu, Xianze Wang, Wenming Wu
Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review). Oncology reports 52 (5) (2024)
Yi Zhou, Zhigang Ji, Weigang Yan, Zhien Zhou, Hanzhong Li, Yu Xiao
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1. Oncology reports 52 (5) (2024)
Zongquan Xu, Yu Chen, Guohui Xu, Cheng Peng, Enyu Liu, Yunguang Li, Jun Niu, Changhai Li
[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level. Oncology reports 52 (5) (2024)
Ning Lu, Mei Zhang, Lu Lu, Yan-Zhao Liu, Hai-Hong Zhang, Xiao-Dong Liu
[Retracted] miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma. Oncology reports 52 (5) (2024)
Nianjie Zhang, Kunming Wen
The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review). Oncology reports 52 (5) (2024)
Bo Tang, Yi Zhang, Rui Liang, Zhenming Gao, Deguang Sun, Liming Wang
[Retracted] RNAi‑mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug‑resistant hepatocellular carcinoma cells to chemotherapy. Oncology reports 52 (5) (2024)
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Miyuki Yanaka, Guanjie Li, Tomohiro Tanaka, Akira Ohkoshi, Manabu Kawada, Mika K Kaneko, Yukio Katori, Yukinari Kato
Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer. Oncology reports 52 (5) (2024)